{"gene":"PNPLA2","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":2004,"finding":"Desnutrin/PNPLA2 encodes a patatin-domain-containing protein that, when overexpressed, increases triglyceride hydrolysis in cells; it localizes to the cytoplasm as shown by confocal microscopy of EGFP-tagged protein.","method":"Ectopic overexpression in transfected cells with triglyceride hydrolysis assay; confocal microscopy of EGFP-fusion protein","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — original biochemical identification with direct enzymatic activity measurement and localization, foundational paper","pmids":["15337759"],"is_preprint":false},{"year":2006,"finding":"Mutations in PNPLA2 (ATGL) cause neutral lipid storage disease with myopathy (NLSDM); truncating mutations preserve the patatin catalytic domain but disrupt the hydrophobic domain, and siRNA knockdown of ATGL mimics the triglyceride degradation block.","method":"Human genetic sequencing; siRNA knockdown with lipid accumulation assay","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — human genetic data corroborated by functional siRNA knockdown, replicated across subsequent studies","pmids":["17187067"],"is_preprint":false},{"year":2006,"finding":"Human PNPLA2/ATGL has triglyceride hydrolase activity but lacks diglyceride hydrolase activity in vitro, distinguishing it from HSL; this was demonstrated by transfecting Cos-7 cells with ATGL cDNA and measuring tri- and diglyceride hydrolase activities.","method":"In vitro lipase activity assay in transfected Cos-7 cells; selective HSL inhibitor controls","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro enzymatic characterization with substrate specificity determination","pmids":["16752181"],"is_preprint":false},{"year":2009,"finding":"Perilipin (PLIN1) sequesters CGI-58 (ABHD5) with high affinity under basal conditions, suppressing its interaction with ATGL; PKA-mediated phosphorylation of perilipin at S492 or S517 releases CGI-58, allowing it to directly interact with ATGL primarily on lipid droplets to stimulate lipolysis.","method":"Live-cell protein trafficking imaging; co-immunoprecipitation; FRET-based interaction assays in adipocytes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (Co-IP, live imaging, phospho-site mapping) in one study","pmids":["19850935"],"is_preprint":false},{"year":2009,"finding":"FoxO1 directly binds to the ATGL promoter at two FoxO1-binding sites and activates ATGL transcription; insulin controls FoxO1 nucleo-cytoplasmic shuttling to regulate ATGL expression and thereby basal and stimulated lipolysis in adipocytes.","method":"Luciferase reporter assay with ATGL promoter; FoxO1 knockdown in 3T3-L1 adipocytes; lentiviral FoxO1 overexpression; ChIP-implied promoter analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing FoxO1 as a direct transcriptional activator of ATGL","pmids":["19297333"],"is_preprint":false},{"year":2010,"finding":"The C-terminal hydrophobic domain of ATGL is required for lipid droplet targeting and CGI-58-independent lipid droplet degradation; CGI-58 can partially rescue LD turnover by an ATGL mutant lacking this domain. G0S2 inhibits ATGL activity by directly binding ATGL independently of its activity state or CGI-58 presence, and cannot be overridden by combined CGI-58/ATGL expression.","method":"Loss-of-function ATGL C-terminal deletion mutants; co-expression experiments; LD morphology analysis; G0S2 binding assays","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 — domain deletion and co-expression experiments, single lab","pmids":["20676045"],"is_preprint":false},{"year":2011,"finding":"ATGL-mediated lipolysis generates lipid ligands required for PPAR-α and PPAR-δ activation; in ATGL-deficient mouse hearts, decreased PPAR-α/δ signaling leads to reduced PGC-1α/β expression, disrupted mitochondrial oxidation, and lethal cardiomyopathy, all of which are fully rescued by pharmacological PPAR-α agonist treatment.","method":"Whole-body ATGL knockout mice; PPAR-α agonist rescue experiments; mitochondrial respiration assays; gene expression analysis; cardiac function assessment","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 1-2 — genetic KO combined with pharmacological rescue and mechanistic epistasis, highly cited foundational study","pmids":["21857651"],"is_preprint":false},{"year":2011,"finding":"ATGL (desnutrin) is phosphorylated by AMPK at serine 406, which increases its TAG hydrolase activity; adipose-specific ATGL ablation converts brown adipose tissue to a WAT-like phenotype with severely impaired thermogenesis and decreased PPARα binding to the UCP-1 promoter.","method":"In vitro AMPK phosphorylation assay; S406 phospho-site mutagenesis; adipose-specific ATGL knockout mice; thermogenesis and gene expression analysis","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1-2 — direct phosphorylation demonstrated in vitro with mutagenesis, corroborated by in vivo adipose-specific KO, replicated in 2016 study","pmids":["21641555"],"is_preprint":false},{"year":2011,"finding":"Perilipin 5 (LSDP5) directly interacts with ATGL (via FRET/FRAP and Co-IP) and recruits ATGL to lipid droplet surfaces, but unlike CGI-58, this interaction decreases lipolysis; PKA phosphorylation of perilipin 5 releases ATGL-mediated lipolysis. Neither perilipin 1 nor 2 interacted directly with ATGL.","method":"Anisotropy FRET, Co-immunoprecipitation, [32P]orthophosphate radiolabeling, lipolysis assay in cell culture","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal biophysical and biochemical methods in a single study","pmids":["21393244"],"is_preprint":false},{"year":2011,"finding":"SIRT1 controls ATGL transcription by deacetylating FoxO1, which then directly binds the ATGL promoter to regulate its expression; SIRT1 knockdown reduces ATGL transcription and attenuates lipolysis in cultured adipocytes.","method":"shRNA knockdown of SIRT1; FoxO1 acetylation assay; ATGL promoter-driven reporter assay; lipolysis measurement","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods in single lab establishing SIRT1-FoxO1-ATGL transcriptional axis","pmids":["21743036"],"is_preprint":false},{"year":2011,"finding":"GBF1 (Arf1 exchange factor) directly interacts with ATGL through multiple contact sites: the ATGL C-terminal region binds the GBF1 Sec7 domain, and the patatin domain of ATGL binds GBF1 HDS1 and HDS2 domains; GBF1/Arf1/COPI pathway is required for ATGL delivery to lipid droplets.","method":"Yeast two-hybrid; Co-immunoprecipitation in mammalian cells; direct protein-binding assays; LD localization imaging","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — three orthogonal interaction methods, single lab","pmids":["21789191"],"is_preprint":false},{"year":2013,"finding":"UBXD8 directly binds ATGL and promotes dissociation of its coactivator CGI-58, thereby inhibiting ATGL activity and increasing lipid droplet size; UBXD8 is restricted to the ER by UBAC2, and its trafficking to LDs recruits p97/VCP to control ATGL-mediated triglyceride hydrolysis.","method":"Co-immunoprecipitation; UBXD8/UBAC2 expression manipulation; LD size measurement; triglyceride hydrolysis assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — direct binding demonstrated, functional consequence of ATGL inhibition measured with mechanistic detail, strong methods","pmids":["23297223"],"is_preprint":false},{"year":2013,"finding":"Insulin inhibits lipolysis via an mTORC1-Egr1-ATGL pathway: mTORC1 promotes Egr1 expression (via 4E-BP-mediated translation), and Egr1 directly inhibits the ATGL promoter in vitro and ATGL expression in adipocytes, reducing lipolysis.","method":"Yeast genetic screen (Msn4/Tor1 ortholog identification); luciferase reporter assay with ATGL promoter; Egr1 knockdown/overexpression in adipocytes; mTORC1 inhibitors; high-fat diet mouse model","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — genetic screen plus in vitro promoter assay plus in vivo validation, evolutionarily conserved pathway established","pmids":["23858058"],"is_preprint":false},{"year":2013,"finding":"ATGL-catalyzed lipolysis in pancreatic β-cells generates PPARδ ligands that maintain mitochondrial oxidative function required for glucose-stimulated insulin secretion; β-cell-specific ATGL ablation impairs mitochondrial respiration and ATP production, and PPARδ agonist (but not PPARα) restores this defect.","method":"β-cell-specific ATGL KO mice; glucose-stimulated insulin secretion assay; mitochondrial respiration; PPARδ agonist rescue; adenoviral ATGL re-expression in KO islets","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1-2 — tissue-specific KO with pharmacological and genetic rescue, multiple orthogonal readouts","pmids":["24268737"],"is_preprint":false},{"year":2014,"finding":"FSP27 (fat-specific protein 27) directly interacts with ATGL through a core domain (amino acids 120-220) to inhibit ATGL lipolytic function and promote triglyceride storage; FSP27 depletion increases lipolysis via ATGL, leading to FFA-induced inhibition of insulin signaling.","method":"Co-immunoprecipitation; FSP27 domain deletion mapping; FSP27 knockdown; ATGL KO mouse fibroblasts; lipolysis and AKT phosphorylation assays in human adipocytes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — domain-level interaction mapping plus functional rescue in multiple cell systems","pmids":["24627478"],"is_preprint":false},{"year":2014,"finding":"Hepatic ATGL preferentially channels hydrolyzed fatty acids to β-oxidation and induces PPARα signaling through an L-FABP-independent mechanism, as shown by ATGL knockdown/overexpression in L-FABP KO mice and primary hepatocytes.","method":"Adenovirus-mediated hepatic ATGL knockdown/overexpression; L-FABP KO mice; FA oxidation assay in primary hepatocytes; PPARα target gene expression","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 — genetic dissection using double KO model, single lab","pmids":["24610891"],"is_preprint":false},{"year":2016,"finding":"AMPK phosphorylates ATGL (desnutrin) at S406 in vivo to increase its TAG hydrolase activity and promote basal lipolysis in adipose tissue; adipose-specific AMPK double KO mice show defective ATGL S406 phosphorylation and reduced basal lipolysis.","method":"Adipose-specific AMPK (α1/α2) double knockout mice; S406 phosphorylation analysis; TAG hydrolase activity assay; adipocyte lipolysis measurement","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo genetic KO corroborating in vitro phosphorylation finding from 2011, replication across two independent studies","pmids":["27185873"],"is_preprint":false},{"year":2016,"finding":"E3 ubiquitin ligase COP1 (RFWD2) binds the consensus VP motif of ATGL and targets it for proteasomal degradation via K48-linked polyubiquitination predominantly at lysine 100; COP1 depletion by adenovirus in mice ameliorates high-fat diet-induced hepatic steatosis.","method":"Co-immunoprecipitation; ubiquitination assay with K48 linkage specificity; site-directed mutagenesis (K100); adenovirus-mediated COP1 knockdown in HFD mice; hepatic TG measurement","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1-2 — mechanistic site identification with mutagenesis and in vivo validation","pmids":["27658392"],"is_preprint":false},{"year":2019,"finding":"ATGL functions as a transacylase when HSL is deficient: it transfers an acyl group from one DAG to another, forming TG plus monoglyceride, providing an alternative lipolytic pathway; this transacylase activity was demonstrated using radiolabeled DAG substrates with HSL-deficient lipid droplet fractions and ATGL-specific inhibitor.","method":"Radiolabeled DAG hydrolysis/transacylation assay with lipid droplet fractions from HSL-deficient adipose tissue; ATGL-specific inhibitor (Atglistatin)","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 1 — direct biochemical assay with specific inhibitor, single lab","pmids":["31035700"],"is_preprint":false},{"year":2020,"finding":"OSBPL2 (ORP2) links the ER with lipid droplets, binds COPB1, and mediates ATGL transport from the ER to the LD surface; loss of OSBPL2 impairs ATGL translocation and lipid droplet lipolysis.","method":"Co-immunoprecipitation; OSBPL2 knockout; LD lipolysis assay; localization imaging","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 — direct protein-protein interaction and trafficking demonstrated, single lab","pmids":["32650117"],"is_preprint":false},{"year":2022,"finding":"ATGL catalyzes a transacylation reaction to biosynthesize fatty acid esters of hydroxy fatty acids (FAHFAs): it uses TG or DG as acyl donors to esterify hydroxy fatty acids. Overexpression of wild-type but not catalytically dead ATGL increases FAHFA biosynthesis; adipose-specific ATGL KO reduces endogenous FAHFA and FAHFA-TG levels by 80-90%.","method":"Recombinant ATGL transacylation assay in vitro; catalytically dead mutant overexpression; adipose-specific ATGL KO mice; chemical biology/proteomics identification; DGAT activity manipulation","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutant controls, validated in vivo with tissue-specific KO, multiple orthogonal methods","pmids":["35676490"],"is_preprint":false},{"year":2022,"finding":"STX11 (syntaxin-11) directly binds ATGL through its C-terminus interacting with the patatin domain of ATGL, prevents ATGL spatial translocation to LDs by recruiting it to the ER, and thereby inhibits lipid droplet degradation and lipophagy; STX11 deficiency promotes ATGL-SIRT1 signaling to enhance lipophagy.","method":"Co-immunoprecipitation with domain mapping; STX11 overexpression/knockdown; LD degradation assay; ATGL localization imaging","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct interaction with domain mapping, functional localization consequence, single lab","pmids":["35372814"],"is_preprint":false},{"year":2024,"finding":"zDHHC11 S-acylates ATGL at cysteine 15; preventing S-acylation at C15 renders ATGL catalytically inactive despite proper lipid droplet localization, causing LD accumulation and defective lipolysis/lipophagy. zDHHC11 overexpression reduces LD size; its elimination enlarges LDs.","method":"zDHHC11 KO/overexpression; C15 ATGL mutagenesis; lipolysis assay; LD morphology; S-acylation biochemical assay in hepatocyte cultures and mice","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 1 — S-acylation site identified by mutagenesis with catalytic consequence established in vitro and in vivo","pmids":["39143266"],"is_preprint":false},{"year":2024,"finding":"PNPLA3(I148M) promotes hepatic steatosis by accumulating on lipid droplets and sequestering ABHD5 away from ATGL, thereby inhibiting ATGL-mediated TG hydrolysis in an ABHD5-dependent gain-of-function mechanism; ABHD5 overexpression reverses steatosis in Pnpla3M/M mice, and PNPLA3 (like ATGL) is activated by ABHD5 in vitro.","method":"NanoBiT complementation assay for protein interactions in hepatocytes; immunocytochemistry; in vitro TG hydrolase activity with purified recombinant proteins; liver-specific Atgl KO mice expressing PNPLA3; AAV-ABHD5 rescue in Pnpla3M/M mice","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution with purified proteins, multiple interaction assays, in vivo genetic rescue, mechanistically rigorous","pmids":["39550037"],"is_preprint":false},{"year":2024,"finding":"Intracellular glucose depletion reduces Golgi PtdIns4P levels, decreasing assembly of the CUL7FBXW8 E3 ligase complex in the Golgi, which leads to reduced polyubiquitylation of ATGL and enhanced ATGL-driven lipolysis; this Golgi PtdIns4P-CUL7FBXW8-ATGL axis constitutes a cell-intrinsic glucose-sensing mechanism controlling lipolysis.","method":"Golgi PtdIns4P manipulation; CUL7FBXW8 complex assembly assay; ATGL ubiquitylation assay; genetic/pharmacological manipulation in mouse steatosis models and ex vivo human liver perfusion","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — mechanistic dissection of ubiquitylation pathway with in vivo and ex vivo human validation","pmids":["38561547"],"is_preprint":false},{"year":2007,"finding":"PEDF (pigment epithelium-derived factor) co-immunoprecipitates with ATGL in hepatic lysates and functions as a receptor-ligand interaction that regulates hepatocyte triglyceride content; PEDF-null hepatocytes have increased TG content that is rescued by recombinant PEDF in an ATGL-dependent manner.","method":"Co-immunoprecipitation; ATGL inhibitor ((R)-bromoenol lactone); rPEDF treatment of PEDF-null hepatocytes; TG content measurement; immunofluorescence localization","journal":"Journal of hepatology","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP plus functional inhibitor rescue, single lab","pmids":["18191271"],"is_preprint":false},{"year":2012,"finding":"ATGL missense mutations (p.Arg221Pro, p.Asn172Lys) within or proximal to the patatin domain result in proteins with near-absent lipolytic activity that still localize correctly to lipid droplets; wild-type ATGL overexpression in patient fibroblasts corrects the metabolic defect and reduces LD accumulation, demonstrating that LD-binding and catalytic activity are separable functions.","method":"ATGL mutant expression in patient fibroblasts; lipid droplet localization imaging; lipolytic activity assay; WT ATGL rescue overexpression","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — structure-function analysis with patient mutations and rescue experiment, single lab","pmids":["22990388"],"is_preprint":false},{"year":2012,"finding":"In skeletal muscle, the ATGL-CGI-58 interaction increases 128% following contraction-induced lipolysis; ATGL interacts with PLIN2, PLIN3, and PLIN5 at rest, but PLIN2-ATGL interaction decreases during stimulation, suggesting PLINs regulate lipolysis by controlling ATGL-CGI-58 association at the lipid droplet surface.","method":"Co-immunoprecipitation from isolated rat soleus at rest vs. tetanic stimulation; quantitative interaction analysis","journal":"American journal of physiology. Regulatory, integrative and comparative physiology","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP in a physiological context, single lab, single method","pmids":["23408028"],"is_preprint":false},{"year":2012,"finding":"Distinct mechanisms regulate ATGL-mediated lipolysis by LD coat proteins: perilipin 1 directly inhibits ATGL triacylglycerol hydrolase activity in vitro and attenuates CGI-58-dependent ATGL activation, whereas FSP27 constitutively limits ATGL presence on LDs. Isoproterenol-stimulated ATGL translocation to LDs requires perilipin 1.","method":"In vitro TG hydrolase activity assay; perilipin/FSP27 knockdown; ATGL overexpression; LD morphology and ATGL localization imaging in adipocytes","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"Medium","confidence_rationale":"Tier 1-2 — in vitro inhibition assay combined with cell-based loss-of-function, single lab","pmids":["23204327"],"is_preprint":false},{"year":2017,"finding":"Lipid droplet-associated hydrolase (LDAH) enhances K48-linked polyubiquitination and proteasomal degradation of ATGL, promoting TAG accumulation; co-expression of ATGL reverses LDAH-induced LD phenotype changes.","method":"LDAH overexpression/knockdown; pulse-chase TAG turnover assay; ubiquitination assay; ATGL co-expression rescue; LD morphology analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — ubiquitination assay and functional rescue, single lab","pmids":["28578400"],"is_preprint":false},{"year":2008,"finding":"ATGL protein is expressed in human skeletal muscle exclusively in type I (oxidative) fibers, as demonstrated by immunohistochemical and immunofluorescent staining of vastus lateralis muscle biopsies, indicating a fiber-type specific role in intramuscular fatty acid handling.","method":"Immunohistochemistry and immunofluorescence on human skeletal muscle biopsies with fiber-type co-staining","journal":"Histochemistry and cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct protein localization with functional inference, first demonstration in human tissue","pmids":["18224330"],"is_preprint":false},{"year":2015,"finding":"ATGL overexpression in skeletal muscle myotubes increases lipolysis, activates PPARδ transcriptional activity, and enhances mitochondrial oxidative capacity; these transcriptional responses are specific to ATGL-mediated lipolysis and not a generalized increase in fatty acid flux.","method":"Adenoviral and AAV-mediated ATGL overexpression in C2C12 myotubes and mouse tibialis anterior; PPARδ reporter assay; mitochondrial respiration measurement","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — specific pathway activation demonstrated with direct overexpression and reporter assay, single lab","pmids":["25852007"],"is_preprint":false}],"current_model":"PNPLA2/ATGL is the rate-limiting triacylglycerol lipase that initiates intracellular lipolysis via its patatin-domain catalytic activity, is activated by CGI-58 (ABHD5) binding, regulated post-translationally by AMPK-mediated phosphorylation at S406, COP1-mediated K48 polyubiquitination at K100, and zDHHC11-mediated S-acylation at C15 (required for catalytic activity), and is controlled at the lipid droplet surface by perilipin 1/5, G0S2, FSP27, UBXD8, STX11, and GBF1/Arf1/COPI trafficking; beyond triglyceride hydrolysis, ATGL performs transacylation reactions to synthesize FAHFAs, and the fatty acids it liberates serve as ligands for PPAR-α/δ nuclear receptors to regulate mitochondrial biogenesis and energy metabolism in heart, adipose, muscle, liver, and β-cells."},"narrative":{"teleology":[{"year":2004,"claim":"The identity of the enzyme initiating triglyceride hydrolysis was unknown; cloning and expression of desnutrin/PNPLA2 established it as a patatin-domain lipase that increases TG hydrolysis when overexpressed, founding the field of ATGL biology.","evidence":"Ectopic overexpression in transfected cells with TG hydrolysis assay and EGFP-fusion confocal microscopy","pmids":["15337759"],"confidence":"High","gaps":["Endogenous substrate specificity not determined","In vivo physiological role not established","Coactivator/corepressor requirements unknown"]},{"year":2006,"claim":"Whether ATGL had unique substrate specificity versus HSL was unclear; in vitro assays demonstrated that ATGL hydrolyzes TG but not DG, establishing its non-redundant role as the first step of lipolysis, and human genetic studies linked PNPLA2 mutations to NLSDM.","evidence":"In vitro lipase activity in Cos-7 cells with substrate specificity determination; human genetic sequencing with siRNA knockdown validation","pmids":["16752181","17187067"],"confidence":"High","gaps":["Crystal structure of patatin domain not solved","Mechanism of LD targeting not resolved"]},{"year":2009,"claim":"How ATGL is activated at lipid droplets was unknown; studies showed that perilipin 1 sequesters the coactivator CGI-58 under basal conditions, and PKA-mediated perilipin phosphorylation releases CGI-58 to directly bind and stimulate ATGL on LDs, establishing the hormonal lipolysis cascade.","evidence":"Live-cell imaging, Co-IP, and FRET in adipocytes; FoxO1 promoter binding and transcriptional regulation studies","pmids":["19850935","19297333"],"confidence":"High","gaps":["Structural basis of CGI-58–ATGL interaction unknown","Relative contribution of transcriptional vs. post-translational control not quantified"]},{"year":2011,"claim":"Multiple regulatory layers converged: AMPK was shown to directly phosphorylate ATGL at S406 to enhance activity; perilipin 5 was identified as an inhibitory LD scaffold releasing ATGL upon PKA phosphorylation; GBF1/Arf1/COPI was found to traffic ATGL to LDs; and ATGL-deficient hearts revealed that ATGL-liberated fatty acids serve as essential PPARα/δ ligands for mitochondrial biogenesis, with agonist rescue of lethal cardiomyopathy.","evidence":"In vitro AMPK phosphorylation with S406 mutagenesis; FRET/Co-IP for PLIN5; yeast two-hybrid/Co-IP for GBF1; whole-body and adipose-specific ATGL KO mice with PPARα agonist rescue","pmids":["21641555","21393244","21789191","21857651"],"confidence":"High","gaps":["Kinase-phosphatase balance at S406 in vivo not defined","Whether PPARα vs PPARδ preference is tissue-specific not fully resolved"]},{"year":2012,"claim":"How LD coat proteins differentially regulate ATGL was unclear; studies demonstrated that patatin-domain missense mutations abolish catalysis while preserving LD localization (separating these functions), perilipin 1 directly inhibits ATGL activity in vitro while FSP27 limits ATGL presence on LDs, and contraction increases ATGL–CGI-58 association in skeletal muscle.","evidence":"Patient mutation structure-function analysis with rescue; in vitro TG hydrolase inhibition assays; Co-IP from stimulated skeletal muscle","pmids":["22990388","23204327","23408028"],"confidence":"Medium","gaps":["Structural mechanism of perilipin 1 direct inhibition unknown","Quantitative stoichiometry of LD coat interactions not determined"]},{"year":2013,"claim":"Additional inhibitory and transcriptional mechanisms were identified: UBXD8 was shown to bind ATGL and displace CGI-58 at LDs via p97/VCP recruitment, insulin was found to suppress ATGL transcription through mTORC1–Egr1, and β-cell-specific ATGL KO revealed PPARδ (not PPARα) as the downstream mediator of ATGL-dependent mitochondrial function in islets.","evidence":"Co-IP and LD size assays for UBXD8; ATGL promoter reporter with Egr1 manipulation; β-cell-specific ATGL KO with PPARδ agonist rescue","pmids":["23297223","23858058","24268737"],"confidence":"High","gaps":["Whether UBXD8 regulation is hormonally controlled not established","Identity of specific fatty acid species acting as PPAR ligands not determined"]},{"year":2014,"claim":"FSP27 was mapped to a core domain (aa 120–220) that directly binds and inhibits ATGL, and hepatic ATGL was shown to preferentially channel hydrolyzed FAs to β-oxidation and PPARα signaling independently of L-FABP.","evidence":"Domain deletion mapping with Co-IP; hepatic ATGL knockdown/overexpression in L-FABP KO mice","pmids":["24627478","24610891"],"confidence":"High","gaps":["FA channeling mechanism without L-FABP not molecularly defined","FSP27 inhibition mechanism at atomic level unknown"]},{"year":2016,"claim":"AMPK phosphorylation of ATGL at S406 was validated in vivo using adipose-specific AMPK double KO mice, and COP1 was identified as the first E3 ligase targeting ATGL for K48-linked proteasomal degradation at K100.","evidence":"Adipose-specific AMPK α1/α2 double KO with S406 phosphorylation analysis; COP1 Co-IP, ubiquitination assay with K100 mutagenesis, in vivo HFD rescue","pmids":["27185873","27658392"],"confidence":"High","gaps":["Whether COP1 and AMPK pathways are coordinated not tested","Deubiquitinase for ATGL not identified"]},{"year":2019,"claim":"Beyond hydrolysis, ATGL was shown to possess transacylase activity, transferring acyl groups between DAG molecules to form TG plus MAG, providing an alternative lipolytic route when HSL is absent.","evidence":"Radiolabeled DAG transacylation assay with HSL-deficient LD fractions and Atglistatin inhibitor","pmids":["31035700"],"confidence":"Medium","gaps":["Physiological significance of transacylation in HSL-sufficient cells unclear","Structural basis for dual hydrolase/transacylase activity unknown"]},{"year":2022,"claim":"ATGL's transacylase activity was shown to be the principal biosynthetic enzyme for FAHFAs, a bioactive lipid class, with adipose-specific KO reducing FAHFA levels by 80–90%; separately, STX11 was identified as a new inhibitor that retains ATGL in the ER to prevent LD translocation.","evidence":"Recombinant ATGL transacylation assay with catalytic-dead mutant; adipose-specific ATGL KO FAHFA quantification; STX11 Co-IP with domain mapping and localization imaging","pmids":["35676490","35372814"],"confidence":"High","gaps":["FAHFA transacylation substrate selectivity rules not defined","How STX11 vs GBF1 pathways coordinate ATGL trafficking unclear"]},{"year":2024,"claim":"Two new regulatory axes were revealed: zDHHC11-mediated S-acylation at C15 was shown to be required for ATGL catalytic activity (not LD localization), and a Golgi PtdIns4P–CUL7/FBXW8 ubiquitylation pathway was identified as a glucose-sensing mechanism controlling ATGL protein levels and lipolysis; additionally, PNPLA3(I148M) was shown to cause steatosis by sequestering ABHD5 from ATGL.","evidence":"C15 mutagenesis with S-acylation assay in hepatocytes and mice; Golgi PtdIns4P manipulation with CUL7/FBXW8 assembly and ATGL ubiquitylation assays including ex vivo human liver; NanoBiT and in vitro reconstitution for PNPLA3–ABHD5–ATGL axis","pmids":["39143266","38561547","39550037"],"confidence":"High","gaps":["How S-acylation at C15 enables catalysis structurally is unknown","Interplay between COP1 and CUL7/FBXW8 ubiquitylation pathways not resolved","Full-length ATGL structure remains unsolved"]},{"year":null,"claim":"A high-resolution structure of full-length ATGL (with and without CGI-58) is needed to explain how S-acylation at C15 enables catalysis, how the patatin domain coordinates hydrolase vs. transacylase activities, and how multiple inhibitory proteins (G0S2, FSP27, PLIN1, UBXD8, STX11) achieve non-redundant regulation at the LD surface.","evidence":"","pmids":[],"confidence":"High","gaps":["No atomic-resolution structure of ATGL or ATGL–CGI-58 complex","Deubiquitinase(s) for ATGL not identified","How specific FA species from ATGL hydrolysis are channeled to PPARα vs PPARδ remains undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,2,7,16,20,26]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[18,20]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[5,26]}],"localization":[{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[3,5,8,26,28]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[21]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,2,7,16,20]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,13,31]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,9,12]}],"complexes":[],"partners":["ABHD5","PLIN1","PLIN5","G0S2","CIDEC","UBXD8","GBF1","STX11"],"other_free_text":[]},"mechanistic_narrative":"PNPLA2 (ATGL) is the rate-limiting triacylglycerol lipase that initiates intracellular lipolysis across adipose tissue, heart, liver, skeletal muscle, and pancreatic β-cells, and additionally functions as a transacylase catalyzing FAHFA biosynthesis [PMID:15337759, PMID:16752181, PMID:35676490]. Its patatin-domain serine hydrolase activity is activated by the coactivator CGI-58/ABHD5—released from perilipin 1 upon PKA-mediated phosphorylation—and is stimulated by AMPK phosphorylation at S406 and zDHHC11-mediated S-acylation at C15, while inhibited by G0S2, FSP27, perilipin 5, UBXD8, and STX11 at the lipid droplet surface [PMID:19850935, PMID:21641555, PMID:39143266, PMID:20676045, PMID:24627478, PMID:23297223]. ATGL protein turnover is controlled by COP1-mediated K48 polyubiquitination at K100 and a Golgi PtdIns4P–CUL7/FBXW8 ubiquitylation axis that couples glucose availability to lipolysis [PMID:27658392, PMID:38561547]. Loss-of-function mutations in PNPLA2 cause neutral lipid storage disease with myopathy (NLSDM), and the fatty acids liberated by ATGL serve as endogenous ligands for PPARα/δ nuclear receptors to sustain mitochondrial oxidative metabolism and thermogenesis [PMID:17187067, PMID:21857651, PMID:24268737]."},"prefetch_data":{"uniprot":{"accession":"Q96AD5","full_name":"Patatin-like phospholipase domain-containing protein 2","aliases":["Adipose triglyceride lipase","Calcium-independent phospholipase A2-zeta","iPLA2-zeta","Desnutrin","Pigment epithelium-derived factor receptor","PEDF-R","TTS2.2","Transport-secretion protein 2","TTS2"],"length_aa":504,"mass_kda":55.3,"function":"Catalyzes the initial step in triglyceride hydrolysis in adipocyte and non-adipocyte lipid droplets (PubMed:15364929, PubMed:15550674, PubMed:16150821, PubMed:16239926, PubMed:17603008, PubMed:34903883). Exhibits a strong preference for the hydrolysis of long-chain fatty acid esters at the sn-2 position of the glycerol backbone and acts coordinately with LIPE/HLS and DGAT2 within the lipolytic cascade (By similarity). Also possesses acylglycerol transacylase and phospholipase A2 activities (PubMed:15364929, PubMed:17032652, PubMed:17603008). Transfers fatty acid from triglyceride to retinol, hydrolyzes retinylesters, and generates 1,3-diacylglycerol from triglycerides (PubMed:17603008). Regulates adiposome size and may be involved in the degradation of adiposomes (PubMed:16239926). Catalyzes the formation of an ester bond between hydroxy fatty acids and fatty acids derived from triglycerides or diglycerides to generate fatty acid esters of hydroxy fatty acids (FAHFAs) in adipocytes (PubMed:35676490). Acts antagonistically with LDAH in regulation of cellular lipid stores (PubMed:28578400). Inhibits LDAH-stimulated lipid droplet fusion (PubMed:28578400). May play an important role in energy homeostasis (By similarity). May play a role in the response of the organism to starvation, enhancing hydrolysis of triglycerides and providing free fatty acids to other tissues to be oxidized in situations of energy depletion (By similarity)","subcellular_location":"Lipid droplet; Cell membrane; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q96AD5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PNPLA2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000177666","cell_line_id":"CID001821","localizations":[{"compartment":"vesicles","grade":3}],"interactors":[],"url":"https://opencell.sf.czbiohub.org/target/CID001821","total_profiled":1310},"omim":[{"mim_id":"613248","title":"PERILIPIN 5; PLIN5","url":"https://www.omim.org/entry/613248"},{"mim_id":"610717","title":"NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM","url":"https://www.omim.org/entry/610717"},{"mim_id":"609567","title":"PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 3; PNPLA3","url":"https://www.omim.org/entry/609567"},{"mim_id":"609059","title":"PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 2; PNPLA2","url":"https://www.omim.org/entry/609059"},{"mim_id":"606416","title":"NLR FAMILY, PYRIN DOMAIN-CONTAINING 3; NLRP3","url":"https://www.omim.org/entry/606416"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Lipid droplets","reliability":"Enhanced"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"adipose tissue","ntpm":487.2},{"tissue":"breast","ntpm":357.1}],"url":"https://www.proteinatlas.org/search/PNPLA2"},"hgnc":{"alias_symbol":["desnutrin","TTS-2.2","ATGL","FP17548","iPLA2zeta"],"prev_symbol":[]},"alphafold":{"accession":"Q96AD5","domains":[{"cath_id":"-","chopping":"10-260_297-313","consensus_level":"high","plddt":90.0141,"start":10,"end":313},{"cath_id":"-","chopping":"316-386","consensus_level":"medium","plddt":78.8575,"start":316,"end":386}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96AD5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96AD5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96AD5-F1-predicted_aligned_error_v6.png","plddt_mean":72.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PNPLA2","jax_strain_url":"https://www.jax.org/strain/search?query=PNPLA2"},"sequence":{"accession":"Q96AD5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96AD5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96AD5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96AD5"}},"corpus_meta":[{"pmid":"21857651","id":"PMC_21857651","title":"ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1.","date":"2011","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21857651","citation_count":641,"is_preprint":false},{"pmid":"15337759","id":"PMC_15337759","title":"Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15337759","citation_count":502,"is_preprint":false},{"pmid":"21641555","id":"PMC_21641555","title":"Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype.","date":"2011","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21641555","citation_count":428,"is_preprint":false},{"pmid":"17187067","id":"PMC_17187067","title":"The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy.","date":"2006","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17187067","citation_count":382,"is_preprint":false},{"pmid":"19850935","id":"PMC_19850935","title":"Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl).","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19850935","citation_count":312,"is_preprint":false},{"pmid":"19401457","id":"PMC_19401457","title":"Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5.","date":"2009","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19401457","citation_count":238,"is_preprint":false},{"pmid":"21393244","id":"PMC_21393244","title":"Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21393244","citation_count":229,"is_preprint":false},{"pmid":"27185873","id":"PMC_27185873","title":"AMPK Phosphorylates Desnutrin/ATGL and Hormone-Sensitive Lipase To Regulate Lipolysis and Fatty Acid Oxidation within Adipose Tissue.","date":"2016","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27185873","citation_count":226,"is_preprint":false},{"pmid":"23297223","id":"PMC_23297223","title":"Spatial regulation of UBXD8 and p97/VCP controls ATGL-mediated lipid droplet turnover.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23297223","citation_count":193,"is_preprint":false},{"pmid":"19297333","id":"PMC_19297333","title":"FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19297333","citation_count":186,"is_preprint":false},{"pmid":"29764424","id":"PMC_29764424","title":"Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation.","date":"2018","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29764424","citation_count":174,"is_preprint":false},{"pmid":"16705060","id":"PMC_16705060","title":"The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-alpha in 3T3-L1 adipocytes and is a target for transactivation by PPARgamma.","date":"2006","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16705060","citation_count":168,"is_preprint":false},{"pmid":"19050316","id":"PMC_19050316","title":"Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL.","date":"2008","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/19050316","citation_count":163,"is_preprint":false},{"pmid":"26196542","id":"PMC_26196542","title":"Impact of Reduced ATGL-Mediated Adipocyte Lipolysis on Obesity-Associated Insulin Resistance and Inflammation in Male Mice.","date":"2015","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26196542","citation_count":158,"is_preprint":false},{"pmid":"21743036","id":"PMC_21743036","title":"SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL.","date":"2011","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/21743036","citation_count":154,"is_preprint":false},{"pmid":"30367950","id":"PMC_30367950","title":"Of mice and men: The physiological role of adipose triglyceride lipase (ATGL).","date":"2018","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/30367950","citation_count":138,"is_preprint":false},{"pmid":"23858058","id":"PMC_23858058","title":"Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23858058","citation_count":131,"is_preprint":false},{"pmid":"18191271","id":"PMC_18191271","title":"Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL).","date":"2007","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/18191271","citation_count":112,"is_preprint":false},{"pmid":"24268737","id":"PMC_24268737","title":"Desnutrin/ATGL activates PPARδ to promote mitochondrial function for insulin secretion in islet β cells.","date":"2013","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24268737","citation_count":103,"is_preprint":false},{"pmid":"35676490","id":"PMC_35676490","title":"ATGL is a biosynthetic enzyme for fatty acid esters of hydroxy fatty acids.","date":"2022","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/35676490","citation_count":102,"is_preprint":false},{"pmid":"24627478","id":"PMC_24627478","title":"Fat-specific protein 27 (FSP27) interacts with adipose triglyceride lipase (ATGL) to regulate lipolysis and insulin sensitivity in human adipocytes.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24627478","citation_count":100,"is_preprint":false},{"pmid":"27759039","id":"PMC_27759039","title":"LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL).","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27759039","citation_count":96,"is_preprint":false},{"pmid":"22984285","id":"PMC_22984285","title":"Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) deficiencies affect expression of lipolytic activities in mouse adipose tissues.","date":"2012","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/22984285","citation_count":96,"is_preprint":false},{"pmid":"20676045","id":"PMC_20676045","title":"Differential control of ATGL-mediated lipid droplet degradation by CGI-58 and G0S2.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/20676045","citation_count":95,"is_preprint":false},{"pmid":"22374972","id":"PMC_22374972","title":"Fasting energy homeostasis in mice with adipose deficiency of desnutrin/adipose triglyceride lipase.","date":"2012","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/22374972","citation_count":86,"is_preprint":false},{"pmid":"24002947","id":"PMC_24002947","title":"Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia.","date":"2014","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/24002947","citation_count":85,"is_preprint":false},{"pmid":"35675775","id":"PMC_35675775","title":"ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35675775","citation_count":83,"is_preprint":false},{"pmid":"21544567","id":"PMC_21544567","title":"The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene.","date":"2011","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21544567","citation_count":81,"is_preprint":false},{"pmid":"25753422","id":"PMC_25753422","title":"PGC-1/Spargel Counteracts High-Fat-Diet-Induced Obesity and Cardiac Lipotoxicity Downstream of TOR and Brummer ATGL Lipase.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25753422","citation_count":81,"is_preprint":false},{"pmid":"23408028","id":"PMC_23408028","title":"Skeletal muscle PLIN proteins, ATGL and CGI-58, interactions at rest and following stimulated contraction.","date":"2013","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23408028","citation_count":76,"is_preprint":false},{"pmid":"16752181","id":"PMC_16752181","title":"Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity.","date":"2006","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/16752181","citation_count":76,"is_preprint":false},{"pmid":"29472527","id":"PMC_29472527","title":"Hints on ATGL implications in cancer: beyond bioenergetic clues.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29472527","citation_count":70,"is_preprint":false},{"pmid":"25202121","id":"PMC_25202121","title":"Lipid droplet protein LID-1 mediates ATGL-1-dependent lipolysis during fasting in Caenorhabditis elegans.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25202121","citation_count":70,"is_preprint":false},{"pmid":"26318046","id":"PMC_26318046","title":"Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26318046","citation_count":69,"is_preprint":false},{"pmid":"26508640","id":"PMC_26508640","title":"Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26508640","citation_count":67,"is_preprint":false},{"pmid":"22687626","id":"PMC_22687626","title":"Fenofibrate lowers lipid accumulation in myotubes by modulating the PPARα/AMPK/FoxO1/ATGL pathway.","date":"2012","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22687626","citation_count":63,"is_preprint":false},{"pmid":"27559856","id":"PMC_27559856","title":"ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2.","date":"2016","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/27559856","citation_count":58,"is_preprint":false},{"pmid":"27658392","id":"PMC_27658392","title":"Ubiquitin Ligase COP1 Controls Hepatic Fat Metabolism by Targeting ATGL for Degradation.","date":"2016","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/27658392","citation_count":58,"is_preprint":false},{"pmid":"32729974","id":"PMC_32729974","title":"The novel non-steroidal MR antagonist finerenone improves metabolic parameters in high-fat diet-fed mice and activates brown adipose tissue via AMPK-ATGL pathway.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32729974","citation_count":57,"is_preprint":false},{"pmid":"29986925","id":"PMC_29986925","title":"Coordination Among Lipid Droplets, Peroxisomes, and Mitochondria Regulates Energy Expenditure Through the CIDE-ATGL-PPARα Pathway in Adipocytes.","date":"2018","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/29986925","citation_count":56,"is_preprint":false},{"pmid":"18224330","id":"PMC_18224330","title":"Adipose triglyceride lipase (ATGL) expression in human skeletal muscle is type I (oxidative) fiber specific.","date":"2008","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18224330","citation_count":56,"is_preprint":false},{"pmid":"21789191","id":"PMC_21789191","title":"Interaction between the triglyceride lipase ATGL and the Arf1 activator GBF1.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21789191","citation_count":54,"is_preprint":false},{"pmid":"24836204","id":"PMC_24836204","title":"A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.","date":"2014","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/24836204","citation_count":50,"is_preprint":false},{"pmid":"20471263","id":"PMC_20471263","title":"Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene.","date":"2010","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/20471263","citation_count":48,"is_preprint":false},{"pmid":"30367149","id":"PMC_30367149","title":"Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30367149","citation_count":47,"is_preprint":false},{"pmid":"22990388","id":"PMC_22990388","title":"Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22990388","citation_count":47,"is_preprint":false},{"pmid":"18189154","id":"PMC_18189154","title":"Developmental, hormonal, and nutritional regulation of porcine adipose triglyceride lipase (ATGL).","date":"2008","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/18189154","citation_count":46,"is_preprint":false},{"pmid":"27677764","id":"PMC_27677764","title":"A beta cell ATGL-lipolysis/adipose tissue axis controls energy homeostasis and body weight via insulin secretion in mice.","date":"2016","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/27677764","citation_count":45,"is_preprint":false},{"pmid":"25852007","id":"PMC_25852007","title":"ATGL-mediated triglyceride turnover and the regulation of mitochondrial capacity in skeletal muscle.","date":"2015","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25852007","citation_count":42,"is_preprint":false},{"pmid":"23204327","id":"PMC_23204327","title":"Distinct mechanisms regulate ATGL-mediated adipocyte lipolysis by lipid droplet coat proteins.","date":"2012","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23204327","citation_count":42,"is_preprint":false},{"pmid":"20336671","id":"PMC_20336671","title":"17beta-estradiol supplementation attenuates ovariectomy-induced increases in ATGL signaling and reduced perilipin expression in visceral adipose tissue.","date":"2010","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20336671","citation_count":41,"is_preprint":false},{"pmid":"18657972","id":"PMC_18657972","title":"Distal lipid storage myopathy due to PNPLA2 mutation.","date":"2008","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/18657972","citation_count":41,"is_preprint":false},{"pmid":"24610891","id":"PMC_24610891","title":"Hepatic ATGL mediates PPAR-α signaling and fatty acid channeling through an L-FABP independent mechanism.","date":"2014","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/24610891","citation_count":39,"is_preprint":false},{"pmid":"27396333","id":"PMC_27396333","title":"Regulation of Hepatic Triacylglycerol Metabolism by CGI-58 Does Not Require ATGL Co-activation.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27396333","citation_count":39,"is_preprint":false},{"pmid":"25956450","id":"PMC_25956450","title":"Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings.","date":"2015","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25956450","citation_count":39,"is_preprint":false},{"pmid":"39550037","id":"PMC_39550037","title":"PNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysis.","date":"2024","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/39550037","citation_count":38,"is_preprint":false},{"pmid":"28459858","id":"PMC_28459858","title":"Epistatic interaction between the lipase-encoding genes Pnpla2 and Lipe causes liposarcoma in mice.","date":"2017","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28459858","citation_count":37,"is_preprint":false},{"pmid":"26330055","id":"PMC_26330055","title":"ATGL and CGI-58 are lipid droplet proteins of the hepatic stellate cell line HSC-T6.","date":"2015","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/26330055","citation_count":36,"is_preprint":false},{"pmid":"28194887","id":"PMC_28194887","title":"Atgl deficiency induces podocyte apoptosis and leads to glomerular filtration barrier damage.","date":"2017","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/28194887","citation_count":36,"is_preprint":false},{"pmid":"23296636","id":"PMC_23296636","title":"ERα regulates lipid metabolism in bone through ATGL and perilipin.","date":"2013","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23296636","citation_count":36,"is_preprint":false},{"pmid":"28726642","id":"PMC_28726642","title":"Coordinated transcriptional control of adipocyte triglyceride lipase (Atgl) by transcription factors Sp1 and peroxisome proliferator-activated receptor γ (PPARγ) during adipocyte differentiation.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28726642","citation_count":34,"is_preprint":false},{"pmid":"25890298","id":"PMC_25890298","title":"PEDF and PEDF-derived peptide 44mer stimulate cardiac triglyceride degradation via ATGL.","date":"2015","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25890298","citation_count":33,"is_preprint":false},{"pmid":"19626423","id":"PMC_19626423","title":"Regulation of ATGL expression mediated by leptin in vitro in porcine adipocyte lipolysis.","date":"2009","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19626423","citation_count":33,"is_preprint":false},{"pmid":"31185001","id":"PMC_31185001","title":"Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy.","date":"2019","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/31185001","citation_count":32,"is_preprint":false},{"pmid":"27485820","id":"PMC_27485820","title":"PPARα-ATGL pathway improves muscle mitochondrial metabolism: implication in aging.","date":"2016","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/27485820","citation_count":32,"is_preprint":false},{"pmid":"24817795","id":"PMC_24817795","title":"Inhibition of age-related cytokines production by ATGL: a mechanism linked to the anti-inflammatory effect of resveratrol.","date":"2014","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/24817795","citation_count":31,"is_preprint":false},{"pmid":"26795240","id":"PMC_26795240","title":"Comparative proteomics reveals abnormal binding of ATGL and dysferlin on lipid droplets from pressure overload-induced dysfunctional rat hearts.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26795240","citation_count":31,"is_preprint":false},{"pmid":"33185110","id":"PMC_33185110","title":"Inhibition of ATGL in adipose tissue ameliorates isoproterenol-induced cardiac remodeling by reducing adipose tissue inflammation.","date":"2020","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33185110","citation_count":30,"is_preprint":false},{"pmid":"23145367","id":"PMC_23145367","title":"Distinct roles for alpha-beta hydrolase domain 5 (ABHD5/CGI-58) and adipose triglyceride lipase (ATGL/PNPLA2) in lipid metabolism and signaling.","date":"2012","source":"Adipocyte","url":"https://pubmed.ncbi.nlm.nih.gov/23145367","citation_count":29,"is_preprint":false},{"pmid":"34845203","id":"PMC_34845203","title":"Elevated ATGL in colon cancer cells and cancer stem cells promotes metabolic and tumorigenic reprogramming reinforced by obesity.","date":"2021","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/34845203","citation_count":28,"is_preprint":false},{"pmid":"16551354","id":"PMC_16551354","title":"Application of a sensitive collection heuristic for very large protein families: evolutionary relationship between adipose triglyceride lipase (ATGL) and classic mammalian lipases.","date":"2006","source":"BMC bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/16551354","citation_count":28,"is_preprint":false},{"pmid":"32650117","id":"PMC_32650117","title":"OSBPL2 Is Required for the Binding of COPB1 to ATGL and the Regulation of Lipid Droplet Lipolysis.","date":"2020","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/32650117","citation_count":28,"is_preprint":false},{"pmid":"31311719","id":"PMC_31311719","title":"ATGL-1 mediates the effect of dietary restriction and the insulin/IGF-1 signaling pathway on longevity in C. elegans.","date":"2019","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31311719","citation_count":27,"is_preprint":false},{"pmid":"39357546","id":"PMC_39357546","title":"Inhibition of ATGL alleviates MASH via impaired PPARα signalling that favours hydrophilic bile acid composition in mice.","date":"2024","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/39357546","citation_count":26,"is_preprint":false},{"pmid":"39143266","id":"PMC_39143266","title":"S-acylation of ATGL is required for lipid droplet homoeostasis in hepatocytes.","date":"2024","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/39143266","citation_count":26,"is_preprint":false},{"pmid":"23146629","id":"PMC_23146629","title":"Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23146629","citation_count":26,"is_preprint":false},{"pmid":"31035700","id":"PMC_31035700","title":"An Epistatic Interaction between Pnpla2 and Lipe Reveals New Pathways of Adipose Tissue Lipolysis.","date":"2019","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31035700","citation_count":25,"is_preprint":false},{"pmid":"25814662","id":"PMC_25814662","title":"4E-BPs Control Fat Storage by Regulating the Expression of Egr1 and ATGL.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25814662","citation_count":25,"is_preprint":false},{"pmid":"25287355","id":"PMC_25287355","title":"A myopathy with unusual features caused by PNPLA2 gene mutations.","date":"2015","source":"Muscle & nerve","url":"https://pubmed.ncbi.nlm.nih.gov/25287355","citation_count":25,"is_preprint":false},{"pmid":"33824421","id":"PMC_33824421","title":"Loss of ephrin B2 receptor (EPHB2) sets lipid rheostat by regulating proteins DGAT1 and ATGL inducing lipid droplet storage in prostate cancer cells.","date":"2021","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33824421","citation_count":25,"is_preprint":false},{"pmid":"21073837","id":"PMC_21073837","title":"A novel PNPLA2 mutation causes neutral lipid storage disease with myopathy (NLSDM) presenting muscular dystrophic features with lipid storage and rimmed vacuoles.","date":"2010","source":"Clinical neuropathology","url":"https://pubmed.ncbi.nlm.nih.gov/21073837","citation_count":25,"is_preprint":false},{"pmid":"22815850","id":"PMC_22815850","title":"Higher levels of ATGL are associated with exercise-induced enhancement of lipolysis in rat epididymal adipocytes.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22815850","citation_count":25,"is_preprint":false},{"pmid":"38561547","id":"PMC_38561547","title":"Glucose controls lipolysis through Golgi PtdIns4P-mediated regulation of ATGL.","date":"2024","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/38561547","citation_count":24,"is_preprint":false},{"pmid":"28258942","id":"PMC_28258942","title":"Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement.","date":"2017","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/28258942","citation_count":24,"is_preprint":false},{"pmid":"35912266","id":"PMC_35912266","title":"Recent Advances on the Role of ATGL in Cancer.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35912266","citation_count":23,"is_preprint":false},{"pmid":"35372814","id":"PMC_35372814","title":"The vesicular transporter STX11 governs ATGL-mediated hepatic lipolysis and lipophagy.","date":"2022","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/35372814","citation_count":23,"is_preprint":false},{"pmid":"28578400","id":"PMC_28578400","title":"Lipid Droplet-Associated Hydrolase Promotes Lipid Droplet Fusion and Enhances ATGL Degradation and Triglyceride Accumulation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28578400","citation_count":23,"is_preprint":false},{"pmid":"28179319","id":"PMC_28179319","title":"Adipose Triglyceride Lipase (ATGL) Expression Is Associated with Adiposity and Tumor Stromal Proliferation in Patients with Pancreatic Ductal Adenocarcinoma.","date":"2017","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/28179319","citation_count":23,"is_preprint":false},{"pmid":"34416900","id":"PMC_34416900","title":"Long non-coding RNA NEAT1 facilitates the growth, migration, and invasion of ovarian cancer cells via the let-7 g/MEST/ATGL axis.","date":"2021","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/34416900","citation_count":23,"is_preprint":false},{"pmid":"26882978","id":"PMC_26882978","title":"Depletion of Rab32 decreases intracellular lipid accumulation and induces lipolysis through enhancing ATGL expression in hepatocytes.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26882978","citation_count":23,"is_preprint":false},{"pmid":"27357546","id":"PMC_27357546","title":"Reduced ATGL-mediated lipolysis attenuates β-adrenergic-induced AMPK signaling, but not the induction of PKA-targeted genes, in adipocytes and adipose tissue.","date":"2016","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27357546","citation_count":23,"is_preprint":false},{"pmid":"39326768","id":"PMC_39326768","title":"Blockage of ATGL-mediated breakdown of lipid droplets in microglia alleviates neuroinflammatory and behavioural responses to lipopolysaccharides.","date":"2024","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/39326768","citation_count":22,"is_preprint":false},{"pmid":"32454271","id":"PMC_32454271","title":"Effect of salt promote the muscle triglyceride hydrolysis during dry-salting by inducing the phosphorylation of adipose tissue triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) and lipid droplets splitting.","date":"2020","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32454271","citation_count":22,"is_preprint":false},{"pmid":"36746922","id":"PMC_36746922","title":"Restoration of lipid homeostasis between TG and PE by the LXRα-ATGL/EPT1 axis ameliorates hepatosteatosis.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36746922","citation_count":22,"is_preprint":false},{"pmid":"31550483","id":"PMC_31550483","title":"Hedgehog signaling promotes lipolysis in adipose tissue through directly regulating Bmm/ATGL lipase.","date":"2019","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/31550483","citation_count":22,"is_preprint":false},{"pmid":"33449950","id":"PMC_33449950","title":"Palmitate induces fat accumulation via repressing FoxO1-mediated ATGL-dependent lipolysis in HepG2 hepatocytes.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/33449950","citation_count":21,"is_preprint":false},{"pmid":"22832386","id":"PMC_22832386","title":"Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy.","date":"2012","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22832386","citation_count":21,"is_preprint":false},{"pmid":"23232698","id":"PMC_23232698","title":"Symptomatic lipid storage in carriers for the PNPLA2 gene.","date":"2012","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/23232698","citation_count":21,"is_preprint":false},{"pmid":"39748508","id":"PMC_39748508","title":"ATGL regulates renal fibrosis by reprogramming lipid metabolism during the transition from AKI to CKD.","date":"2025","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/39748508","citation_count":20,"is_preprint":false},{"pmid":"33450726","id":"PMC_33450726","title":"Localized increases in CEPT1 and ATGL elevate plasmalogen phosphatidylcholines in HDLs contributing to atheroprotective lipid profiles in hyperglycemic GCK-MODY.","date":"2021","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/33450726","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50181,"output_tokens":7651,"usd":0.132654},"stage2":{"model":"claude-opus-4-6","input_tokens":11473,"output_tokens":3563,"usd":0.21966},"total_usd":0.352314,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"Desnutrin/PNPLA2 encodes a patatin-domain-containing protein that, when overexpressed, increases triglyceride hydrolysis in cells; it localizes to the cytoplasm as shown by confocal microscopy of EGFP-tagged protein.\",\n      \"method\": \"Ectopic overexpression in transfected cells with triglyceride hydrolysis assay; confocal microscopy of EGFP-fusion protein\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original biochemical identification with direct enzymatic activity measurement and localization, foundational paper\",\n      \"pmids\": [\"15337759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Mutations in PNPLA2 (ATGL) cause neutral lipid storage disease with myopathy (NLSDM); truncating mutations preserve the patatin catalytic domain but disrupt the hydrophobic domain, and siRNA knockdown of ATGL mimics the triglyceride degradation block.\",\n      \"method\": \"Human genetic sequencing; siRNA knockdown with lipid accumulation assay\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human genetic data corroborated by functional siRNA knockdown, replicated across subsequent studies\",\n      \"pmids\": [\"17187067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Human PNPLA2/ATGL has triglyceride hydrolase activity but lacks diglyceride hydrolase activity in vitro, distinguishing it from HSL; this was demonstrated by transfecting Cos-7 cells with ATGL cDNA and measuring tri- and diglyceride hydrolase activities.\",\n      \"method\": \"In vitro lipase activity assay in transfected Cos-7 cells; selective HSL inhibitor controls\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro enzymatic characterization with substrate specificity determination\",\n      \"pmids\": [\"16752181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Perilipin (PLIN1) sequesters CGI-58 (ABHD5) with high affinity under basal conditions, suppressing its interaction with ATGL; PKA-mediated phosphorylation of perilipin at S492 or S517 releases CGI-58, allowing it to directly interact with ATGL primarily on lipid droplets to stimulate lipolysis.\",\n      \"method\": \"Live-cell protein trafficking imaging; co-immunoprecipitation; FRET-based interaction assays in adipocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (Co-IP, live imaging, phospho-site mapping) in one study\",\n      \"pmids\": [\"19850935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"FoxO1 directly binds to the ATGL promoter at two FoxO1-binding sites and activates ATGL transcription; insulin controls FoxO1 nucleo-cytoplasmic shuttling to regulate ATGL expression and thereby basal and stimulated lipolysis in adipocytes.\",\n      \"method\": \"Luciferase reporter assay with ATGL promoter; FoxO1 knockdown in 3T3-L1 adipocytes; lentiviral FoxO1 overexpression; ChIP-implied promoter analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing FoxO1 as a direct transcriptional activator of ATGL\",\n      \"pmids\": [\"19297333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The C-terminal hydrophobic domain of ATGL is required for lipid droplet targeting and CGI-58-independent lipid droplet degradation; CGI-58 can partially rescue LD turnover by an ATGL mutant lacking this domain. G0S2 inhibits ATGL activity by directly binding ATGL independently of its activity state or CGI-58 presence, and cannot be overridden by combined CGI-58/ATGL expression.\",\n      \"method\": \"Loss-of-function ATGL C-terminal deletion mutants; co-expression experiments; LD morphology analysis; G0S2 binding assays\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — domain deletion and co-expression experiments, single lab\",\n      \"pmids\": [\"20676045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ATGL-mediated lipolysis generates lipid ligands required for PPAR-α and PPAR-δ activation; in ATGL-deficient mouse hearts, decreased PPAR-α/δ signaling leads to reduced PGC-1α/β expression, disrupted mitochondrial oxidation, and lethal cardiomyopathy, all of which are fully rescued by pharmacological PPAR-α agonist treatment.\",\n      \"method\": \"Whole-body ATGL knockout mice; PPAR-α agonist rescue experiments; mitochondrial respiration assays; gene expression analysis; cardiac function assessment\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic KO combined with pharmacological rescue and mechanistic epistasis, highly cited foundational study\",\n      \"pmids\": [\"21857651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ATGL (desnutrin) is phosphorylated by AMPK at serine 406, which increases its TAG hydrolase activity; adipose-specific ATGL ablation converts brown adipose tissue to a WAT-like phenotype with severely impaired thermogenesis and decreased PPARα binding to the UCP-1 promoter.\",\n      \"method\": \"In vitro AMPK phosphorylation assay; S406 phospho-site mutagenesis; adipose-specific ATGL knockout mice; thermogenesis and gene expression analysis\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct phosphorylation demonstrated in vitro with mutagenesis, corroborated by in vivo adipose-specific KO, replicated in 2016 study\",\n      \"pmids\": [\"21641555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Perilipin 5 (LSDP5) directly interacts with ATGL (via FRET/FRAP and Co-IP) and recruits ATGL to lipid droplet surfaces, but unlike CGI-58, this interaction decreases lipolysis; PKA phosphorylation of perilipin 5 releases ATGL-mediated lipolysis. Neither perilipin 1 nor 2 interacted directly with ATGL.\",\n      \"method\": \"Anisotropy FRET, Co-immunoprecipitation, [32P]orthophosphate radiolabeling, lipolysis assay in cell culture\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal biophysical and biochemical methods in a single study\",\n      \"pmids\": [\"21393244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SIRT1 controls ATGL transcription by deacetylating FoxO1, which then directly binds the ATGL promoter to regulate its expression; SIRT1 knockdown reduces ATGL transcription and attenuates lipolysis in cultured adipocytes.\",\n      \"method\": \"shRNA knockdown of SIRT1; FoxO1 acetylation assay; ATGL promoter-driven reporter assay; lipolysis measurement\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods in single lab establishing SIRT1-FoxO1-ATGL transcriptional axis\",\n      \"pmids\": [\"21743036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GBF1 (Arf1 exchange factor) directly interacts with ATGL through multiple contact sites: the ATGL C-terminal region binds the GBF1 Sec7 domain, and the patatin domain of ATGL binds GBF1 HDS1 and HDS2 domains; GBF1/Arf1/COPI pathway is required for ATGL delivery to lipid droplets.\",\n      \"method\": \"Yeast two-hybrid; Co-immunoprecipitation in mammalian cells; direct protein-binding assays; LD localization imaging\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — three orthogonal interaction methods, single lab\",\n      \"pmids\": [\"21789191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"UBXD8 directly binds ATGL and promotes dissociation of its coactivator CGI-58, thereby inhibiting ATGL activity and increasing lipid droplet size; UBXD8 is restricted to the ER by UBAC2, and its trafficking to LDs recruits p97/VCP to control ATGL-mediated triglyceride hydrolysis.\",\n      \"method\": \"Co-immunoprecipitation; UBXD8/UBAC2 expression manipulation; LD size measurement; triglyceride hydrolysis assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding demonstrated, functional consequence of ATGL inhibition measured with mechanistic detail, strong methods\",\n      \"pmids\": [\"23297223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Insulin inhibits lipolysis via an mTORC1-Egr1-ATGL pathway: mTORC1 promotes Egr1 expression (via 4E-BP-mediated translation), and Egr1 directly inhibits the ATGL promoter in vitro and ATGL expression in adipocytes, reducing lipolysis.\",\n      \"method\": \"Yeast genetic screen (Msn4/Tor1 ortholog identification); luciferase reporter assay with ATGL promoter; Egr1 knockdown/overexpression in adipocytes; mTORC1 inhibitors; high-fat diet mouse model\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic screen plus in vitro promoter assay plus in vivo validation, evolutionarily conserved pathway established\",\n      \"pmids\": [\"23858058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ATGL-catalyzed lipolysis in pancreatic β-cells generates PPARδ ligands that maintain mitochondrial oxidative function required for glucose-stimulated insulin secretion; β-cell-specific ATGL ablation impairs mitochondrial respiration and ATP production, and PPARδ agonist (but not PPARα) restores this defect.\",\n      \"method\": \"β-cell-specific ATGL KO mice; glucose-stimulated insulin secretion assay; mitochondrial respiration; PPARδ agonist rescue; adenoviral ATGL re-expression in KO islets\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — tissue-specific KO with pharmacological and genetic rescue, multiple orthogonal readouts\",\n      \"pmids\": [\"24268737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FSP27 (fat-specific protein 27) directly interacts with ATGL through a core domain (amino acids 120-220) to inhibit ATGL lipolytic function and promote triglyceride storage; FSP27 depletion increases lipolysis via ATGL, leading to FFA-induced inhibition of insulin signaling.\",\n      \"method\": \"Co-immunoprecipitation; FSP27 domain deletion mapping; FSP27 knockdown; ATGL KO mouse fibroblasts; lipolysis and AKT phosphorylation assays in human adipocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain-level interaction mapping plus functional rescue in multiple cell systems\",\n      \"pmids\": [\"24627478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Hepatic ATGL preferentially channels hydrolyzed fatty acids to β-oxidation and induces PPARα signaling through an L-FABP-independent mechanism, as shown by ATGL knockdown/overexpression in L-FABP KO mice and primary hepatocytes.\",\n      \"method\": \"Adenovirus-mediated hepatic ATGL knockdown/overexpression; L-FABP KO mice; FA oxidation assay in primary hepatocytes; PPARα target gene expression\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic dissection using double KO model, single lab\",\n      \"pmids\": [\"24610891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"AMPK phosphorylates ATGL (desnutrin) at S406 in vivo to increase its TAG hydrolase activity and promote basal lipolysis in adipose tissue; adipose-specific AMPK double KO mice show defective ATGL S406 phosphorylation and reduced basal lipolysis.\",\n      \"method\": \"Adipose-specific AMPK (α1/α2) double knockout mice; S406 phosphorylation analysis; TAG hydrolase activity assay; adipocyte lipolysis measurement\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo genetic KO corroborating in vitro phosphorylation finding from 2011, replication across two independent studies\",\n      \"pmids\": [\"27185873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"E3 ubiquitin ligase COP1 (RFWD2) binds the consensus VP motif of ATGL and targets it for proteasomal degradation via K48-linked polyubiquitination predominantly at lysine 100; COP1 depletion by adenovirus in mice ameliorates high-fat diet-induced hepatic steatosis.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assay with K48 linkage specificity; site-directed mutagenesis (K100); adenovirus-mediated COP1 knockdown in HFD mice; hepatic TG measurement\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mechanistic site identification with mutagenesis and in vivo validation\",\n      \"pmids\": [\"27658392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ATGL functions as a transacylase when HSL is deficient: it transfers an acyl group from one DAG to another, forming TG plus monoglyceride, providing an alternative lipolytic pathway; this transacylase activity was demonstrated using radiolabeled DAG substrates with HSL-deficient lipid droplet fractions and ATGL-specific inhibitor.\",\n      \"method\": \"Radiolabeled DAG hydrolysis/transacylation assay with lipid droplet fractions from HSL-deficient adipose tissue; ATGL-specific inhibitor (Atglistatin)\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical assay with specific inhibitor, single lab\",\n      \"pmids\": [\"31035700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"OSBPL2 (ORP2) links the ER with lipid droplets, binds COPB1, and mediates ATGL transport from the ER to the LD surface; loss of OSBPL2 impairs ATGL translocation and lipid droplet lipolysis.\",\n      \"method\": \"Co-immunoprecipitation; OSBPL2 knockout; LD lipolysis assay; localization imaging\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein-protein interaction and trafficking demonstrated, single lab\",\n      \"pmids\": [\"32650117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ATGL catalyzes a transacylation reaction to biosynthesize fatty acid esters of hydroxy fatty acids (FAHFAs): it uses TG or DG as acyl donors to esterify hydroxy fatty acids. Overexpression of wild-type but not catalytically dead ATGL increases FAHFA biosynthesis; adipose-specific ATGL KO reduces endogenous FAHFA and FAHFA-TG levels by 80-90%.\",\n      \"method\": \"Recombinant ATGL transacylation assay in vitro; catalytically dead mutant overexpression; adipose-specific ATGL KO mice; chemical biology/proteomics identification; DGAT activity manipulation\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutant controls, validated in vivo with tissue-specific KO, multiple orthogonal methods\",\n      \"pmids\": [\"35676490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"STX11 (syntaxin-11) directly binds ATGL through its C-terminus interacting with the patatin domain of ATGL, prevents ATGL spatial translocation to LDs by recruiting it to the ER, and thereby inhibits lipid droplet degradation and lipophagy; STX11 deficiency promotes ATGL-SIRT1 signaling to enhance lipophagy.\",\n      \"method\": \"Co-immunoprecipitation with domain mapping; STX11 overexpression/knockdown; LD degradation assay; ATGL localization imaging\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct interaction with domain mapping, functional localization consequence, single lab\",\n      \"pmids\": [\"35372814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"zDHHC11 S-acylates ATGL at cysteine 15; preventing S-acylation at C15 renders ATGL catalytically inactive despite proper lipid droplet localization, causing LD accumulation and defective lipolysis/lipophagy. zDHHC11 overexpression reduces LD size; its elimination enlarges LDs.\",\n      \"method\": \"zDHHC11 KO/overexpression; C15 ATGL mutagenesis; lipolysis assay; LD morphology; S-acylation biochemical assay in hepatocyte cultures and mice\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — S-acylation site identified by mutagenesis with catalytic consequence established in vitro and in vivo\",\n      \"pmids\": [\"39143266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PNPLA3(I148M) promotes hepatic steatosis by accumulating on lipid droplets and sequestering ABHD5 away from ATGL, thereby inhibiting ATGL-mediated TG hydrolysis in an ABHD5-dependent gain-of-function mechanism; ABHD5 overexpression reverses steatosis in Pnpla3M/M mice, and PNPLA3 (like ATGL) is activated by ABHD5 in vitro.\",\n      \"method\": \"NanoBiT complementation assay for protein interactions in hepatocytes; immunocytochemistry; in vitro TG hydrolase activity with purified recombinant proteins; liver-specific Atgl KO mice expressing PNPLA3; AAV-ABHD5 rescue in Pnpla3M/M mice\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution with purified proteins, multiple interaction assays, in vivo genetic rescue, mechanistically rigorous\",\n      \"pmids\": [\"39550037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Intracellular glucose depletion reduces Golgi PtdIns4P levels, decreasing assembly of the CUL7FBXW8 E3 ligase complex in the Golgi, which leads to reduced polyubiquitylation of ATGL and enhanced ATGL-driven lipolysis; this Golgi PtdIns4P-CUL7FBXW8-ATGL axis constitutes a cell-intrinsic glucose-sensing mechanism controlling lipolysis.\",\n      \"method\": \"Golgi PtdIns4P manipulation; CUL7FBXW8 complex assembly assay; ATGL ubiquitylation assay; genetic/pharmacological manipulation in mouse steatosis models and ex vivo human liver perfusion\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mechanistic dissection of ubiquitylation pathway with in vivo and ex vivo human validation\",\n      \"pmids\": [\"38561547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PEDF (pigment epithelium-derived factor) co-immunoprecipitates with ATGL in hepatic lysates and functions as a receptor-ligand interaction that regulates hepatocyte triglyceride content; PEDF-null hepatocytes have increased TG content that is rescued by recombinant PEDF in an ATGL-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation; ATGL inhibitor ((R)-bromoenol lactone); rPEDF treatment of PEDF-null hepatocytes; TG content measurement; immunofluorescence localization\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP plus functional inhibitor rescue, single lab\",\n      \"pmids\": [\"18191271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ATGL missense mutations (p.Arg221Pro, p.Asn172Lys) within or proximal to the patatin domain result in proteins with near-absent lipolytic activity that still localize correctly to lipid droplets; wild-type ATGL overexpression in patient fibroblasts corrects the metabolic defect and reduces LD accumulation, demonstrating that LD-binding and catalytic activity are separable functions.\",\n      \"method\": \"ATGL mutant expression in patient fibroblasts; lipid droplet localization imaging; lipolytic activity assay; WT ATGL rescue overexpression\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — structure-function analysis with patient mutations and rescue experiment, single lab\",\n      \"pmids\": [\"22990388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In skeletal muscle, the ATGL-CGI-58 interaction increases 128% following contraction-induced lipolysis; ATGL interacts with PLIN2, PLIN3, and PLIN5 at rest, but PLIN2-ATGL interaction decreases during stimulation, suggesting PLINs regulate lipolysis by controlling ATGL-CGI-58 association at the lipid droplet surface.\",\n      \"method\": \"Co-immunoprecipitation from isolated rat soleus at rest vs. tetanic stimulation; quantitative interaction analysis\",\n      \"journal\": \"American journal of physiology. Regulatory, integrative and comparative physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP in a physiological context, single lab, single method\",\n      \"pmids\": [\"23408028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Distinct mechanisms regulate ATGL-mediated lipolysis by LD coat proteins: perilipin 1 directly inhibits ATGL triacylglycerol hydrolase activity in vitro and attenuates CGI-58-dependent ATGL activation, whereas FSP27 constitutively limits ATGL presence on LDs. Isoproterenol-stimulated ATGL translocation to LDs requires perilipin 1.\",\n      \"method\": \"In vitro TG hydrolase activity assay; perilipin/FSP27 knockdown; ATGL overexpression; LD morphology and ATGL localization imaging in adipocytes\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro inhibition assay combined with cell-based loss-of-function, single lab\",\n      \"pmids\": [\"23204327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Lipid droplet-associated hydrolase (LDAH) enhances K48-linked polyubiquitination and proteasomal degradation of ATGL, promoting TAG accumulation; co-expression of ATGL reverses LDAH-induced LD phenotype changes.\",\n      \"method\": \"LDAH overexpression/knockdown; pulse-chase TAG turnover assay; ubiquitination assay; ATGL co-expression rescue; LD morphology analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ubiquitination assay and functional rescue, single lab\",\n      \"pmids\": [\"28578400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ATGL protein is expressed in human skeletal muscle exclusively in type I (oxidative) fibers, as demonstrated by immunohistochemical and immunofluorescent staining of vastus lateralis muscle biopsies, indicating a fiber-type specific role in intramuscular fatty acid handling.\",\n      \"method\": \"Immunohistochemistry and immunofluorescence on human skeletal muscle biopsies with fiber-type co-staining\",\n      \"journal\": \"Histochemistry and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein localization with functional inference, first demonstration in human tissue\",\n      \"pmids\": [\"18224330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ATGL overexpression in skeletal muscle myotubes increases lipolysis, activates PPARδ transcriptional activity, and enhances mitochondrial oxidative capacity; these transcriptional responses are specific to ATGL-mediated lipolysis and not a generalized increase in fatty acid flux.\",\n      \"method\": \"Adenoviral and AAV-mediated ATGL overexpression in C2C12 myotubes and mouse tibialis anterior; PPARδ reporter assay; mitochondrial respiration measurement\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — specific pathway activation demonstrated with direct overexpression and reporter assay, single lab\",\n      \"pmids\": [\"25852007\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PNPLA2/ATGL is the rate-limiting triacylglycerol lipase that initiates intracellular lipolysis via its patatin-domain catalytic activity, is activated by CGI-58 (ABHD5) binding, regulated post-translationally by AMPK-mediated phosphorylation at S406, COP1-mediated K48 polyubiquitination at K100, and zDHHC11-mediated S-acylation at C15 (required for catalytic activity), and is controlled at the lipid droplet surface by perilipin 1/5, G0S2, FSP27, UBXD8, STX11, and GBF1/Arf1/COPI trafficking; beyond triglyceride hydrolysis, ATGL performs transacylation reactions to synthesize FAHFAs, and the fatty acids it liberates serve as ligands for PPAR-α/δ nuclear receptors to regulate mitochondrial biogenesis and energy metabolism in heart, adipose, muscle, liver, and β-cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PNPLA2 (ATGL) is the rate-limiting triacylglycerol lipase that initiates intracellular lipolysis across adipose tissue, heart, liver, skeletal muscle, and pancreatic β-cells, and additionally functions as a transacylase catalyzing FAHFA biosynthesis [PMID:15337759, PMID:16752181, PMID:35676490]. Its patatin-domain serine hydrolase activity is activated by the coactivator CGI-58/ABHD5—released from perilipin 1 upon PKA-mediated phosphorylation—and is stimulated by AMPK phosphorylation at S406 and zDHHC11-mediated S-acylation at C15, while inhibited by G0S2, FSP27, perilipin 5, UBXD8, and STX11 at the lipid droplet surface [PMID:19850935, PMID:21641555, PMID:39143266, PMID:20676045, PMID:24627478, PMID:23297223]. ATGL protein turnover is controlled by COP1-mediated K48 polyubiquitination at K100 and a Golgi PtdIns4P–CUL7/FBXW8 ubiquitylation axis that couples glucose availability to lipolysis [PMID:27658392, PMID:38561547]. Loss-of-function mutations in PNPLA2 cause neutral lipid storage disease with myopathy (NLSDM), and the fatty acids liberated by ATGL serve as endogenous ligands for PPARα/δ nuclear receptors to sustain mitochondrial oxidative metabolism and thermogenesis [PMID:17187067, PMID:21857651, PMID:24268737].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"The identity of the enzyme initiating triglyceride hydrolysis was unknown; cloning and expression of desnutrin/PNPLA2 established it as a patatin-domain lipase that increases TG hydrolysis when overexpressed, founding the field of ATGL biology.\",\n      \"evidence\": \"Ectopic overexpression in transfected cells with TG hydrolysis assay and EGFP-fusion confocal microscopy\",\n      \"pmids\": [\"15337759\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous substrate specificity not determined\", \"In vivo physiological role not established\", \"Coactivator/corepressor requirements unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Whether ATGL had unique substrate specificity versus HSL was unclear; in vitro assays demonstrated that ATGL hydrolyzes TG but not DG, establishing its non-redundant role as the first step of lipolysis, and human genetic studies linked PNPLA2 mutations to NLSDM.\",\n      \"evidence\": \"In vitro lipase activity in Cos-7 cells with substrate specificity determination; human genetic sequencing with siRNA knockdown validation\",\n      \"pmids\": [\"16752181\", \"17187067\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of patatin domain not solved\", \"Mechanism of LD targeting not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"How ATGL is activated at lipid droplets was unknown; studies showed that perilipin 1 sequesters the coactivator CGI-58 under basal conditions, and PKA-mediated perilipin phosphorylation releases CGI-58 to directly bind and stimulate ATGL on LDs, establishing the hormonal lipolysis cascade.\",\n      \"evidence\": \"Live-cell imaging, Co-IP, and FRET in adipocytes; FoxO1 promoter binding and transcriptional regulation studies\",\n      \"pmids\": [\"19850935\", \"19297333\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of CGI-58–ATGL interaction unknown\", \"Relative contribution of transcriptional vs. post-translational control not quantified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Multiple regulatory layers converged: AMPK was shown to directly phosphorylate ATGL at S406 to enhance activity; perilipin 5 was identified as an inhibitory LD scaffold releasing ATGL upon PKA phosphorylation; GBF1/Arf1/COPI was found to traffic ATGL to LDs; and ATGL-deficient hearts revealed that ATGL-liberated fatty acids serve as essential PPARα/δ ligands for mitochondrial biogenesis, with agonist rescue of lethal cardiomyopathy.\",\n      \"evidence\": \"In vitro AMPK phosphorylation with S406 mutagenesis; FRET/Co-IP for PLIN5; yeast two-hybrid/Co-IP for GBF1; whole-body and adipose-specific ATGL KO mice with PPARα agonist rescue\",\n      \"pmids\": [\"21641555\", \"21393244\", \"21789191\", \"21857651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase-phosphatase balance at S406 in vivo not defined\", \"Whether PPARα vs PPARδ preference is tissue-specific not fully resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"How LD coat proteins differentially regulate ATGL was unclear; studies demonstrated that patatin-domain missense mutations abolish catalysis while preserving LD localization (separating these functions), perilipin 1 directly inhibits ATGL activity in vitro while FSP27 limits ATGL presence on LDs, and contraction increases ATGL–CGI-58 association in skeletal muscle.\",\n      \"evidence\": \"Patient mutation structure-function analysis with rescue; in vitro TG hydrolase inhibition assays; Co-IP from stimulated skeletal muscle\",\n      \"pmids\": [\"22990388\", \"23204327\", \"23408028\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural mechanism of perilipin 1 direct inhibition unknown\", \"Quantitative stoichiometry of LD coat interactions not determined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Additional inhibitory and transcriptional mechanisms were identified: UBXD8 was shown to bind ATGL and displace CGI-58 at LDs via p97/VCP recruitment, insulin was found to suppress ATGL transcription through mTORC1–Egr1, and β-cell-specific ATGL KO revealed PPARδ (not PPARα) as the downstream mediator of ATGL-dependent mitochondrial function in islets.\",\n      \"evidence\": \"Co-IP and LD size assays for UBXD8; ATGL promoter reporter with Egr1 manipulation; β-cell-specific ATGL KO with PPARδ agonist rescue\",\n      \"pmids\": [\"23297223\", \"23858058\", \"24268737\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether UBXD8 regulation is hormonally controlled not established\", \"Identity of specific fatty acid species acting as PPAR ligands not determined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"FSP27 was mapped to a core domain (aa 120–220) that directly binds and inhibits ATGL, and hepatic ATGL was shown to preferentially channel hydrolyzed FAs to β-oxidation and PPARα signaling independently of L-FABP.\",\n      \"evidence\": \"Domain deletion mapping with Co-IP; hepatic ATGL knockdown/overexpression in L-FABP KO mice\",\n      \"pmids\": [\"24627478\", \"24610891\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"FA channeling mechanism without L-FABP not molecularly defined\", \"FSP27 inhibition mechanism at atomic level unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"AMPK phosphorylation of ATGL at S406 was validated in vivo using adipose-specific AMPK double KO mice, and COP1 was identified as the first E3 ligase targeting ATGL for K48-linked proteasomal degradation at K100.\",\n      \"evidence\": \"Adipose-specific AMPK α1/α2 double KO with S406 phosphorylation analysis; COP1 Co-IP, ubiquitination assay with K100 mutagenesis, in vivo HFD rescue\",\n      \"pmids\": [\"27185873\", \"27658392\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether COP1 and AMPK pathways are coordinated not tested\", \"Deubiquitinase for ATGL not identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Beyond hydrolysis, ATGL was shown to possess transacylase activity, transferring acyl groups between DAG molecules to form TG plus MAG, providing an alternative lipolytic route when HSL is absent.\",\n      \"evidence\": \"Radiolabeled DAG transacylation assay with HSL-deficient LD fractions and Atglistatin inhibitor\",\n      \"pmids\": [\"31035700\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological significance of transacylation in HSL-sufficient cells unclear\", \"Structural basis for dual hydrolase/transacylase activity unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"ATGL's transacylase activity was shown to be the principal biosynthetic enzyme for FAHFAs, a bioactive lipid class, with adipose-specific KO reducing FAHFA levels by 80–90%; separately, STX11 was identified as a new inhibitor that retains ATGL in the ER to prevent LD translocation.\",\n      \"evidence\": \"Recombinant ATGL transacylation assay with catalytic-dead mutant; adipose-specific ATGL KO FAHFA quantification; STX11 Co-IP with domain mapping and localization imaging\",\n      \"pmids\": [\"35676490\", \"35372814\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"FAHFA transacylation substrate selectivity rules not defined\", \"How STX11 vs GBF1 pathways coordinate ATGL trafficking unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Two new regulatory axes were revealed: zDHHC11-mediated S-acylation at C15 was shown to be required for ATGL catalytic activity (not LD localization), and a Golgi PtdIns4P–CUL7/FBXW8 ubiquitylation pathway was identified as a glucose-sensing mechanism controlling ATGL protein levels and lipolysis; additionally, PNPLA3(I148M) was shown to cause steatosis by sequestering ABHD5 from ATGL.\",\n      \"evidence\": \"C15 mutagenesis with S-acylation assay in hepatocytes and mice; Golgi PtdIns4P manipulation with CUL7/FBXW8 assembly and ATGL ubiquitylation assays including ex vivo human liver; NanoBiT and in vitro reconstitution for PNPLA3–ABHD5–ATGL axis\",\n      \"pmids\": [\"39143266\", \"38561547\", \"39550037\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How S-acylation at C15 enables catalysis structurally is unknown\", \"Interplay between COP1 and CUL7/FBXW8 ubiquitylation pathways not resolved\", \"Full-length ATGL structure remains unsolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of full-length ATGL (with and without CGI-58) is needed to explain how S-acylation at C15 enables catalysis, how the patatin domain coordinates hydrolase vs. transacylase activities, and how multiple inhibitory proteins (G0S2, FSP27, PLIN1, UBXD8, STX11) achieve non-redundant regulation at the LD surface.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic-resolution structure of ATGL or ATGL–CGI-58 complex\", \"Deubiquitinase(s) for ATGL not identified\", \"How specific FA species from ATGL hydrolysis are channeled to PPARα vs PPARδ remains undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 2, 7, 16, 20, 26]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [18, 20]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [5, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005811\", \"supporting_discovery_ids\": [3, 5, 8, 26, 28]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 2, 7, 16, 20]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 13, 31]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 9, 12]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ABHD5\",\n      \"PLIN1\",\n      \"PLIN5\",\n      \"G0S2\",\n      \"CIDEC\",\n      \"UBXD8\",\n      \"GBF1\",\n      \"STX11\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}